Biogen’s RoActemra Biosimilar Begins EU Approvals Process

The BIIB800 Candidate Is Only the Latest Of Biogen’s Deal-Driven Biosimilars

 
• By Rosalind Rei
  
Vial labelled tocilizumab
• Source: Shutterstock

More from Biosimilars

More from Products